RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/26033031http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26033031http://www.w3.org/2000/01/rdf-schema#comment"PFTK1 was a cell division cycle 2-related serine/threonine protein kinase, which was up-regulated in breast cancer tissues and breast cancer lines. And up-regulated PFTK1 was highly associated with grade, axillary lymph node status, and Ki-67. Moreover, Kaplan-Meier curve showed that up-regulated PFTK1 was related to the poor breast carcinoma patients' overall survival. Here, we first discovered and confirmed that cyclin B was a new interacting protein of PFTK1, and the complex might increase the amount of DVL2, which triggers Wnt/β-catenin signaling pathway. Furthermore, knockdown of PFTK1 attenuated cell proliferation, anchorage-independent cell growth, and cell migration and invasion by inhibiting the transcriptional activation of β-catenin for cyclin D1, MMP9, and HEF1, whereas exogenous expression of PFTK1 might promote MDA-MB-231 cells proliferation, migration, and invasion via promoting PFTK1-DVL2-β-catenin axis. Our findings supported the notion that up-regulated PFTK1 might promote breast cancer progression and metastasis by activating Wnt signaling pathway through the PFTK1-DVL2-β-catenin axis."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.org/dc/terms/identifier"doi:10.1007/s12032-015-0641-8"xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Huang W."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Wang Y."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Zhang C."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Yang S."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Wang H."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Zhu J."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Xu P."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Gu X."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Mao G."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/author"Ni Q."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/date"2015"xsd:gYear
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/name"Med Oncol"xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/pages"195"xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/title"Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer."xsd:string
http://purl.uniprot.org/citations/26033031http://purl.uniprot.org/core/volume"32"xsd:string
http://purl.uniprot.org/citations/26033031http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26033031
http://purl.uniprot.org/citations/26033031http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/26033031
http://purl.uniprot.org/uniprot/#_B4DK59-mappedCitation-26033031http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26033031
http://purl.uniprot.org/uniprot/#_E7EUK8-mappedCitation-26033031http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26033031
http://purl.uniprot.org/uniprot/#_O94921-mappedCitation-26033031http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26033031
http://purl.uniprot.org/uniprot/E7EUK8http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/26033031
http://purl.uniprot.org/uniprot/B4DK59http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/26033031